Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
AbbVie
Diakonhjemmet Hospital
M.D. Anderson Cancer Center
Universitätsklinikum Hamburg-Eppendorf
Future Genetics Limited
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Aalborg University Hospital